美国 · SEC FORM 4
Nuvalent, Inc.
NUVL · — · CIK 0001861560 · Healthcare
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
110 同一窗口内观察到的 Form 4 交易行
39 sales · 71 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2022-11-03 · DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E · $21.8M
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出High
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Noci DarleneChief Development Officer
○▼○▼○○○○
Balcom AlexandraChief Financial Officer
○▼○○○○
Porter James RichardPresident and CEO
○▼○○○○
Pelish Henry E.Chief Scientific Officer
▼○○○○
Turner Christopher DurantChief Medical Officer
○○○○
Lane BenjaminSee Remarks
○○○○
● 买入▼ 卖出○ 其他
Showing the six most active owners; 10 additional owner(s) remain in Form 4 申报证据.
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2022-11-03 · DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E.
近期 Form 4 活动
0买入
166卖出
108其他 Form 4 交易行
71SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出39 sale line(s) · 仅供背景
其他71 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2022-11-03 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | 买入 (P) | Class A Common Stock | 650,000 | USD 33.50 | USD 21,775,000 | SEC 申报 ↗ |
| 2022-11-03 | Hack Andrew A. F. | 买入 (P) | Class A Common Stock | 149,253 | USD 33.50 | USD 4,999,976 | SEC 申报 ↗ |
| 2021-08-02 | Hack Andrew A. F. | 买入 (P) | Class A Common Stock | 735,000 | USD 17.00 | USD 12,495,000 | SEC 申报 ↗ |
Form 4 申报证据
274 transaction lines in the latest 365-day window; 895 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | U (U) | Class A Common Stock | 5,146 | USD 124.00 | USD 638,104 | SEC 申报 ↗ |
| 2026-07-15 | DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | D (D) | Class A Common Stock - Restricted Stock Units | 3,444 | USD 124.00 | USD 427,056 | SEC 申报 ↗ |
| 2026-07-15 | DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | D (D) | Class A Common Stock | 8,949,225 | USD 124.00 | USD 1,109,703,900 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | U (U) | Class A Common Stock | 5,146 | USD 124.00 | USD 638,104 | SEC 申报 ↗ |
| 2026-07-15 | DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | D (D) | Class A Common Stock - Restricted Stock Units | 3,444 | USD 124.00 | USD 427,056 | SEC 申报 ↗ |
| 2026-07-15 | DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt IV, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Flynn James E | D (D) | Class A Common Stock | 8,949,225 | USD 124.00 | USD 1,109,703,900 | SEC 申报 ↗ |
| 2026-07-15 | Wheeler Cameron | U (U) | Class A Common Stock | 5,146 | USD 124.00 | USD 638,104 | SEC 申报 ↗ |
| 2026-07-15 | Wheeler Cameron | D (D) | Class A Common Stock - Restricted Stock Units | 3,444 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Turner Christopher Durant | U (U) | Class A Common Stock | 31,530 | USD 124.00 | USD 3,909,720 | SEC 申报 ↗ |
| 2026-07-15 | Turner Christopher Durant | D (D) | Class A Common Stock - Restricted Stock Units | 41,100 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Turner Christopher Durant | D (D) | Class A Common Stock - Performance Stock Units | 14,350 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Turner Christopher Durant | 奖励／授予 (A) | Class A Common Stock - Performance Stock Units | 14,350 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-15 | Srivastava Sapna | U (U) | Class A Common Stock | 5,146 | USD 124.00 | USD 638,104 | SEC 申报 ↗ |
| 2026-07-15 | Srivastava Sapna | D (D) | Class A Common Stock - Restricted Stock Units | 3,444 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Squarer Ron | D (D) | Class A Common Stock - Restricted Stock Units | 6,281 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Protopapas Anna | U (U) | Class A Common Stock | 5,146 | USD 124.00 | USD 638,104 | SEC 申报 ↗ |
| 2026-07-15 | Protopapas Anna | D (D) | Class A Common Stock - Restricted Stock Units | 3,444 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Porter James Richard | U (U) | Class A Common Stock | 203,529 | USD 124.00 | USD 25,237,596 | SEC 申报 ↗ |
| 2026-07-15 | Porter James Richard | D (D) | Class A Common Stock - Restricted Stock Units | 121,350 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Porter James Richard | D (D) | Class A Common Stock - Performance Stock Units | 40,025 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Porter James Richard | 奖励／授予 (A) | Class A Common Stock - Performance Stock Units | 40,025 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-15 | Pelish Henry E. | U (U) | Class A Common Stock | 22,393 | USD 124.00 | USD 2,776,732 | SEC 申报 ↗ |
| 2026-07-15 | Pelish Henry E. | D (D) | Class A Common Stock - Restricted Stock Units | 41,100 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Pelish Henry E. | D (D) | Class A Common Stock - Performance Stock Units | 14,350 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Pelish Henry E. | 奖励／授予 (A) | Class A Common Stock - Performance Stock Units | 14,350 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-15 | Oliger Christy J. | U (U) | Class A Common Stock | 1,324 | USD 124.00 | USD 164,176 | SEC 申报 ↗ |
| 2026-07-15 | Oliger Christy J. | D (D) | Class A Common Stock - Restricted Stock Units | 6,091 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Noci Darlene | U (U) | Class A Common Stock | 17,017 | USD 124.00 | USD 2,110,108 | SEC 申报 ↗ |
| 2026-07-15 | Noci Darlene | D (D) | Class A Common Stock - Restricted Stock Units | 41,100 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Noci Darlene | D (D) | Class A Common Stock - Performance Stock Units | 14,350 | USD — | USD — | SEC 申报 ↗ |
| 2026-07-15 | Noci Darlene | 奖励／授予 (A) | Class A Common Stock - Performance Stock Units | 14,350 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-15 | Miller Deborah Ann | U (U) | Class A Common Stock | 18,534 | USD 124.00 | USD 2,298,216 | SEC 申报 ↗ |
| 2026-07-15 | Miller Deborah Ann | D (D) | Class A Common Stock - Restricted Stock Units | 41,100 | USD — | USD — | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | NUVL |
| CIK | 0001861560 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | — |
数据覆盖
| 本地 Form 4 历史 | 895 transaction lines from 2021-08-02 to 2026-07-15 3 P purchase lines · 585 S sale lines · 307 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.